To include your compound in the COVID-19 Resource Center, submit it here.

CASI raises $50M in private placement

Cancer company CASI Pharmaceuticals Inc. (NASDAQ:CASI) raised $50

Read the full 89 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE